Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Demyelination and other neurological adverse events after anti-TNF therapy.
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
Teriflunomide for oral therapy in multiple sclerosis.
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
Interleukin-6 control of early Theiler's Murine Encephalomyelitis Virus replication in macrophages occurs in conjunction with STAT1 activation and nitric oxide production.
Fluctuations of MS births and UV-light exposure.
Myelin-derived lipids modulate macrophage activity by liver x receptor activation.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis.
Quality improvement and practice-based research in neurology using the electronic medical record.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
316
317
318
319
320
321
322
323
324
…
next ›
last »